Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Czendlik

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Thrombosis and Haemostasis|April 22, 1985
Cold promoted activation and factor XII, prekallikrein and C1-inhibitorC Czendlik, B Lämmle, F Duckert
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 11, 2011
Pharmacokinetics of the monohydroxy derivative of oxcarbazepine and its enantiomers after a single intravenous dose given as racemate compared with a single oral dose of oxcarbazepineG Flesch, C Czendlik, D Renard, et al.
Thrombosis and Haemostasis|April 30, 1984
Amidolytic prekallikrein (PK) assay: unsuitability of Cephotest as an activatorB Lämmle, A Lohri, T H Tran, et al.
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|May 3, 1983
[Interaction: Modifast--oral anticoagulation]M Christe, J Fritschi, C Czendlik, et al.
Biopharmaceutics & Drug Disposition|May 30, 1998
The influence of food on the disposition of the antiepileptic rufinamide in healthy volunteersJ M Cardot, J B Lecaillon, C Czendlik, et al.
Biopharmaceutics & Drug Disposition|April 1, 1993
Influence of food on the disposition of the monoamine oxidase-A inhibitor brofaromine in healthy volunteersP H Degen, J M Cardot, C Czendlik, et al.
Biopharmaceutics & Drug Disposition|August 1, 1994
The influence of food on the disposition of the antiepileptic oxcarbazepine and its major metabolites in healthy volunteersP H Degen, G Flesch, J M Cardot, et al.
Biopharmaceutics & Drug Disposition|August 1, 1997
Comparative bioavailability of letrozole under fed and fasting conditions in 12 healthy subjects after a 2.5 mg single oral administrationA Sioufi, N Sandrenan, J Godbillon, et al.
Schweizerische Medizinische Wochenschrift|October 29, 1983
[Systemic thrombolysis of arterial occlusions of the lower extremities. Comparison of various treatment schedules]B Lämmle, G Noll, M Christe, et al.
Biopharmaceutics & Drug Disposition|January 16, 1998
Absolute bioavailability of letrozole in healthy postmenopausal womenA Sioufi, N Gauducheau, V Pineau, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Thrombosis and Haemostasis|April 22, 1985
Cold promoted activation and factor XII, prekallikrein and C1-inhibitorC Czendlik, B Lämmle, F Duckert
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 11, 2011
Pharmacokinetics of the monohydroxy derivative of oxcarbazepine and its enantiomers after a single intravenous dose given as racemate compared with a single oral dose of oxcarbazepineG Flesch, C Czendlik, D Renard, et al.
Thrombosis and Haemostasis|April 30, 1984
Amidolytic prekallikrein (PK) assay: unsuitability of Cephotest as an activatorB Lämmle, A Lohri, T H Tran, et al.
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|May 3, 1983
[Interaction: Modifast--oral anticoagulation]M Christe, J Fritschi, C Czendlik, et al.
Biopharmaceutics & Drug Disposition|May 30, 1998
The influence of food on the disposition of the antiepileptic rufinamide in healthy volunteersJ M Cardot, J B Lecaillon, C Czendlik, et al.
Biopharmaceutics & Drug Disposition|April 1, 1993
Influence of food on the disposition of the monoamine oxidase-A inhibitor brofaromine in healthy volunteersP H Degen, J M Cardot, C Czendlik, et al.
Biopharmaceutics & Drug Disposition|August 1, 1994
The influence of food on the disposition of the antiepileptic oxcarbazepine and its major metabolites in healthy volunteersP H Degen, G Flesch, J M Cardot, et al.
Biopharmaceutics & Drug Disposition|August 1, 1997
Comparative bioavailability of letrozole under fed and fasting conditions in 12 healthy subjects after a 2.5 mg single oral administrationA Sioufi, N Sandrenan, J Godbillon, et al.
Schweizerische Medizinische Wochenschrift|October 29, 1983
[Systemic thrombolysis of arterial occlusions of the lower extremities. Comparison of various treatment schedules]B Lämmle, G Noll, M Christe, et al.
Biopharmaceutics & Drug Disposition|January 16, 1998
Absolute bioavailability of letrozole in healthy postmenopausal womenA Sioufi, N Gauducheau, V Pineau, et al.
Pageof 1